Identification of a serotonin/glutamate receptor complex implicated in psychosis
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
The psychosis associated with schizophrenia is characterized by alterations in sensory processing and perception. Some antipsychotic drugs were identified by their high affinity for serotonin 5-HT2A receptors (2AR). Drugs that interact with metabotropic glutamate receptors (mGluR) also have potential for the treatment of schizophrenia. The effects of hallucinogenic drugs, such as psilocybin and lysergic acid diethylamide, require the 2AR and resemble some of the core symptoms of schizophrenia. Here we show that the mGluR2 interacts through specific transmembrane helix domains with the 2AR, a member of an unrelated G-protein-coupled receptor family, to form functional complexes in brain cortex. The 2AR-mGluR2 complex triggers unique cellular responses when targeted by hallucinogenic drugs, and activation of mGluR2 abolishes hallucinogen-specific signalling and behavioural responses. In post-mortem human brain from untreated schizophrenic subjects, the 2AR is upregulated and the mGluR2 is downregulated, a pattern that could predispose to psychosis. These regulatory changes indicate that the 2AR-mGluR2 complex may be involved in the altered cortical processes of schizophrenia, and this complex is therefore a promising new target for the treatment of psychosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, the 5HT2A receptor forms a functional heterodimer with the mGluR2 receptor, which evokes allosteric effects on serotonin agonist binding [34];”
From Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans. (2021) · cites this paper as [34]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“this interaction reduces the hallucinogen-specific Gi/o protein signaling and behavior and may account for the lack of hallucinogenic action of 2-bromo-LSD (5) noted above.”
From Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans. (2021) · cites this paper as [34]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Temporal pattern encoding relieves the cellular information bottleneck, where many stimuli must signal through few intracellular pathways to generate diverse and specific cellular responses (30 -32) but complicates the relationship between synthetic target modulators and their cellular and clinical effects.”
From Cytokine Response Is Determined by Duration of Receptor and Signal Transducers and Activators of Transcription 3 (STAT3) Activation (2013) · cites this paper as [31]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Several recent studies of drugs acting at cell surface receptor targets show that the activation mechanisms responsible for their cellular and systemic effects are more complex than accounted for by their classical pharmacological profiles (30 -32).”
From Cytokine Response Is Determined by Duration of Receptor and Signal Transducers and Activators of Transcription 3 (STAT3) Activation (2013) · cites this paper as [31]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Basic local alignment search tool
Altschul, S. F., Gish, W., Miller, W., Myers, E. W., & Lipman, D. J. (1990) · Journal of Molecular Biology · doi:10.1006/jmbi.1990.9999 · Cited by 98,669
Thompson, J. D., Higgins, D. G., & Gibson, T. J. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.22.4673 · Cited by 64,617
Comparative Protein Modelling by Satisfaction of Spatial Restraints
Šali, A., & Blundell, T. L. (1993) · Journal of Molecular Biology · doi:10.1006/jmbi.1993.1626 · Cited by 12,977
Crystal Structure of Rhodopsin: A G Protein-Coupled Receptor
Palczewski, K., Kumasaka, T., Hori, T., Behnke, C. A., Motoshima, H., Fox, B. A., Trong, I. L., Teller, D. C., Okada, T., Stenkamp, R. E., et al. (2000) · Science · doi:10.1126/science.289.5480.739 · Cited by 5,637
High-Resolution Crystal Structure of an Engineered Human β 2 -Adrenergic G Protein–Coupled Receptor
Cherezov, V., Rosenbaum, D. M., Hanson, M. A., Rasmussen, S. G. F., Thian, F. S., Kobilka, T. S., Choi, H.-J., Kuhn, P., Weis, W. I., Kobilka, B. K., et al. (2007) · Science · doi:10.1126/science.1150577 · Cited by 3,264
Patil, S. T., Zhang, L., Martenyi, F., Lowe, S. L., Jackson, K. A., Andreev, B. V., Avedisova, A. S., Bardenstein, L. M., Gurovich, I. Y., Morozova, M. A., et al. (2007) · Nature Medicine · doi:10.1038/nm1632 · Cited by 1,040
Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action
Vollenweider, F. X., Vollenweider-Scherpenhuyzen, M. F. I., Bäbler, A., Vogel, H., & Hell, D. (1998) · NeuroReport · doi:10.1097/00001756-199812010-00024 · Cited by 1,018
Miyamoto, S., Duncan, G. E., Marx, C. E., & Lieberman, J. A. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001556 · Cited by 988
González-Maeso, J., Weisstaub, N. V., Zhou, M., Chan, P., Ivic, L., Ang, R., Lira, A., Bradley-Moore, M., Ge, Y., Zhou, Q., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.008 · Cited by 925
Self-citation
Cited by
Items 701–800 of 835
Sampedro-Viana, D., Cañete, T., Mourelo, L., Oliveras, I., Peralta-Vallejo, N., Tobeña, A., & Fernández‐Teruel, A. (2023) · Physiology & Behavior · doi:10.1016/j.physbeh.2023.114355 · Cited by 2
Sánchez-Florentino, Z. A., Romero-Martínez, B. S., Flores‐Soto, E., Serrano, H., Montaño, L., Valdés‐Tovar, M., Calixto, E., Aquino‐Gálvez, A., López-Riquelme, G. O., Alvarado, R., et al. (2023) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2023.5331 · Cited by 3
Validating Novel Targets for Pharmacological Interventions in Schizophrenia
Wróblewska, B., & Lewis, D. A. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09040522 · Cited by 2
No evidence for direct physical interaction of 5-HT 2A -mGluR2 receptors in vitro or in vivoPreprint
Fordyce, B. A., Chiu, Y.-T., Wright, N. J., Sakamoto, K., Lyons, S. P., Webb, T. S., Tilton, H. E., Walsh, J. J., Marek, G. J., Setola, V., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.28.734515 · Cited by 2
Novel Targets for Drug Treatment in Psychiatry
Kurita, M., García‐Bea, A., & González‐Maeso, J. (2016) · Springer eBooks · doi:10.1007/978-1-4939-2528-5_30 · Cited by 2
Self-citationShaqfah, J., Bédard, D., Nuara, S. G., Gourdon, J. C., Hamadjida, A., Gaudette, F., Beaudry, F., & Huot, P. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178031 · Cited by 1
Zhang, C., Jiang, P., Wang, Y., & Wang, X. (2026) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2026.2649897 · Cited by 1
“A previous study confirmed that 5-HT 2A R and metabotropic glutamate receptor 2 (mGluR2) can be co-expressed in the cerebral cortex and form functional complexes through specific transmembrane helical domains (TM4 and TM5) [39].”
Gattuso, J. J., Kamal, A., Payet, J. M., Havaux, K., Hendey, J., Bezcioglu, B., Phelan, Z. J., Orchard, M., Bhanot, D., Hale, M. W., et al. (2026) · Neuropsychopharmacology · doi:10.1038/s41386-026-02501-3 · Cited by 1
GPCR heteromers: Beyond the monomeric paradigm in neuropsychiatric drug discovery
Ren, P., Li, Y.-F., & Wang, J.-Y. (2026) · Neurotherapeutics · doi:10.1016/j.neurot.2026.e01087 · Cited by 1
Anti-/Propsychotic Drug Signaling via Heteromeric GPCRs—A Balancing Act?
Kondo, M., & Sawa, A. (2011) · Cell · doi:10.1016/j.cell.2011.11.012 · Cited by 1
“A previous report illustrated that the 2AR and mGluR2 receptors physically interact in pyramidal neurons of the somatosensory cortex (González-Maeso et al., 2008).”
BackgroundGlutamatergic Approaches for the Treatment of Schizophrenia
Morrow, J. A., Gilfillan, R. F., & Neale, S. A. (2012) · Royal Society of Chemistry eBooks · doi:10.1039/9781849734943-00056 · Cited by 2
Techniques for the Study of GPCR Heteromerization in Living Cells and Animal Models
Moreno, J. L., Seto, J., Hanks, J. B., & González‐Maeso, J. (2014) · Neuromethods · doi:10.1007/978-1-4939-2187-4_2 · Cited by 1
Self-citationAdrenergic Control of Lymphocyte Dynamics and Inflammation
Suzuki, K. (2016) · Springer eBooks · doi:10.1007/978-4-431-56068-5_33 · Cited by 1
Elucidation of molecular kinetic schemes from macroscopic traces using system identification
Fribourg, M., Logothetis, D. E., González‐Maeso, J., Sealfon, S. C., Iragüen, B. G., Andrés, F. L.-H., & Březina, V. (2017) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005376 · Cited by 1
Self-citationKenakin, T. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-411460-9.00003-3 · Cited by 1
Class C GPCRs: Metabotropic Glutamate Receptors
Hlaváčková, V., Prézeau, L., Pin, J., & Blahoš, J. (2017) · Springer eBooks · doi:10.1007/978-3-319-60174-8_13 · Cited by 2
Orexin 2 Receptor Antagonists from Prefrontal Cortical Circuitry to Rodent Behavioral Screens
Marek, G. J., Chaney, S. F., & Benvenga, M. J. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.82544 · Cited by 2
“Activation of mGlu2 receptors appears to suppress the DOI-induced increases in a number of IEG-like responses in the prefrontal cortex [40, 41, 44, 91].”
BackgroundGarland, S. L., & Heightman, T. D. (2008) · Wiley eBooks · doi:10.1002/9780470423936.ch2 · Cited by 1
Neurobiological Complications of Alcohol and Substance Misuse
Rooke, E. D., Steele, J. D., & Gilbertson, T. (2020) · Springer eBooks · doi:10.1007/978-3-030-36391-8_80 · Cited by 1
An Adaptive Network Model for Sleep Paralysis: The Risk Factors and Working Mechanisms
Huijzer, W., & Treur, J. (2021) · Lecture notes in networks and systems · doi:10.1007/978-3-030-90318-3_44 · Cited by 2
Pinças, H., González‐Maeso, J., Ruf-Zamojski, F. M., & Sealfon, S. C. (2018) · Endocrinology · doi:10.1007/978-3-319-44675-2_6 · Cited by 2
Self-citationGawade, S. P. (2022) · Indian Journal of Pharmaceutical Education and Research · doi:10.5530/ijper.56.2.53 · Cited by 1
Glutamate, Glutamatergic Drugs and Schizophrenia
Muguruza, C., & Callado, L. F. (2022) · Springer eBooks · doi:10.1007/978-3-030-87480-3_17 · Cited by 1
Self-citationNeurobiologische Grundlagen der Wirkung von Psychedelika
Vollenweider, F. X., & Preller, K. H. (2016) · Springer eBooks · doi:10.1007/978-3-642-55214-4_70-1 · Cited by 1
Rescue of Defective G Protein-Coupled Receptor Function by Intermolecular Cooperation
Trehan, A., Jonas, K., Huhtaniemi, I. T., Hanyaloglu, A. C., & Rivero‐Müller, A. (2013) · Methods in pharmacology and toxicology · doi:10.1007/978-1-62703-779-2_13 · Cited by 1
Ortuño, F., & Gutiérrez-Rojasb, L. (2011) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0304-5412(11)70159-7 · Cited by 9
Fuxé, K., & Borroto‐Escuela, D. O. (2022) · Springer eBooks · doi:10.1007/978-3-031-15080-7_189 · Cited by 1
GPCR Heterodimers: Implications for Biased Signaling
Li, L., Li, Y., Zhang, S., Shen, C., Meng, J., & Liu, J. (2025) · Handbook of experimental pharmacology · doi:10.1007/164_2025_762 · Cited by 1
GPCR-G protein fusions: Use in functional dimerization analysis
Milligan, G. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511760334.004 · Cited by 1
Self-citationPsychedelics, Glutamate, and Neuroimaging Studies
SANTOS, R. G. D. (2014) · Anesthesiology · doi:10.1097/aln.0000000000000243 · Cited by 1
On the Role of G Protein-Coupled Receptors Oligomerization
Gómez‐Soler, M., Ahern, S., Fernández‐Dueñas, V., & Ciruela, F. (2011) · The Open Biology Journal · doi:10.2174/1874196701104010047 · Cited by 1
“In addition, the participation of TM4 in the oligomer interface has been demonstrated for the serotonin 5-HT2C receptor homodimer [35], the serotonin 5-HT4 receptor homodimer [36], the chemokine CCR5 receptor homodimer [37], the α-factor pheromone receptor (Ste2) homodimer [38], the corticotrophin releasing hormone/VT…”
BackgroundEngel, M., Snikeris, P., Matosin, N., Newell, K. A., Huang, X., & Frank, E. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4261-6 · Cited by 1
Bockaert, J. (2009) · Wiley eBooks · doi:10.1002/9780470015902.a0000118.pub2 · Cited by 1
Assessment of Single Nucleotide Variants in hGPRC5A Gene Using in-silico ToolsPreprint
Karaali, M. D., Uz, E., & Çelikler, S. (2023) · Research Square · doi:10.21203/rs.3.rs-3576134/v1 · Cited by 1
Nagl, M. (2024) · University of Regensburg Publication Server (University of Regensburg) · doi:10.5283/epub.53449 · Cited by 1
Khan, S. S. (2013) · Summit (Simon Fraser University)
A molecular and behavioural analysis of descending facilitation in a model of joint inflammation
Carr, F. (2013) · UCL Discovery (University College London) · Cited by 1
Biological mechanisms behind clozapine- induced agranulocytosis
Lahdelma, L. (2009) · Helda - University of Helsinki Institutional Repository · Cited by 1
Cachaza, N. C. C. (2012) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya) · Cited by 2
Neuropatologia de l'Alzheimer i les esquizofrènies
Ferrer, I., & Tobeña, A. (2012) · Treballs de la Societat Catalana de Biologia
Animal Models and Procedures for CNS Disorders
Cutler, N. R., Sramek, J. J., Murphy, M. F., Riordan, H., Bieck, P. R., & Carta, A. (2010) · Wiley eBooks · doi:10.1002/9781444318579.ch2
Gil, J. L. (2009) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Brugal, G. N. (2010) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
G-protein-coupled receptor heteromers as new targets for drug development
Franco, R. (2013) · Endocrine Abstracts · doi:10.1530/endoabs.32.s4.3
Harrison, C. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2555
2008: Signaling Breakthroughs of the Year
Adler, E. M. (2009) · Science Signaling · doi:10.1126/scisignal.252eg1
Harrison, C. (2008) · Nature reviews. Neuroscience · doi:10.1038/nrn2362
Piechowski, C. L. (2014) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-6289
Discovery of novel antipsychotics targeting group II metabotropic glutamate receptor
Hiyoshi, T., Chaki, S., & Okuyama, S. (2012) · Folia Pharmacologica Japonica · doi:10.1254/fpj.140.111
Functional Role(s) of Dimeric Complexes Formed from G-Protein-Coupled Receptors
Rozenfeld, R., & Devi, L. A. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374145-5.00028-0
G-Protein-Coupled Receptors Heterodimers and Receptor Mosaics of Different Types of
Marcellino, D. J., Guidolin, D., Woods, A. S., & Agnati, L. F. (2016)
Examining Allosterism in a Dimeric G-Protein-Coupled Receptor Context
Giraldo, J., Ortiz, J., Dalton, J. A. R., & Zhou, B. (2016) · Royal Society of Chemistry eBooks · doi:10.1039/9781782629276-00097
Multi-Layered Architecture of Serotonin 2A Receptor Signaling
Singh, S. P., Panicker, M. M., & Soman, S. (2016) · CRC Press eBooks · doi:10.1201/9781315369334-35
Yeung, D. P. Y. (2015) · TSpace (University of Toronto)
Modulation of N-methyl-D-aspartate receptors by Gαs- and Gαi/o-coupled receptors
Trepanier, C. H. (2013) · TSpace (University of Toronto)
Regulation of the Dopamine D1-D2 Receptor Heterooligomer
Verma, V. (2012) · TSpace (University of Toronto)
Neurobiological determinants of depressive-like symptoms in rodents : A multifactorial approach
Bové, M. (2018) · IRIS Research product catalog (Sapienza University of Rome)
5-HT2A Receptor Heterodimerization
Łukasiewicz, S., Błasiak, E., & Dziedzicka‐Wasylewska, M. (2018) · Springer eBooks · doi:10.1007/978-3-319-70474-6_3
Brown, S., Bush, S. J., SUMMERS, K. M., Hume, D., & Lawrence, A. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/262469
If you give a mouse a mushroom: Behavioral effects of hallucinogens in mice
Klein, L. M. (2018) · eScholarship (California Digital Library)
Muguruza, C., Palomo-Ruiz, J. L., Morentín, B., Callado, L. F., González‐Maeso, J., & Meana, J. J. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.11.500
Self-citationMahatme, N., Shettar, M., Kakunje, A., & Mahatme, N. (2019) · INDIAN JOURNAL OF MENTAL HEALTH AND NEUROSCIENCES · doi:10.32746/ijmhns.2019.v2.i1.13
Sierra, S., Toneatti, R., & González‐Maeso, J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816228-6.00008-8 · Cited by 1
Self-citationFribourg, M. (2019) · UPM Digital Archive (Technical University of Madrid) · doi:10.20868/upm.thesis.57438
Merino, P. (2019) · Wiley eBooks · doi:10.1002/9783527813421.ch3
Jockers, R. (2011) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.13409956.14781055
Takeuchi, T., & Kameda, H. (2013) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.717980799.793471802
(2008) · CRC Press eBooks · doi:10.1201/9780849378812.ch4
Discovery of Subtype Selective Agonists of the Group II Metabotropic Glutamate Receptors
Hao, J. (2022) · Wiley eBooks · doi:10.1002/9781119627784.ch6
Metabolic stress and antipsychotic treatment induced gene expression alterations in human cell
Kálmán, S. (2016) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.2988
D’Aprile, I. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819641-0.00125-0
Serotonin–glutamate receptor complex offers new drug target for psychosis
(2008) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0800
Use of concomitant medication in the treatment of schizophrenia
Oosthuizen, F., & Bodenstein, J. (2015) · African Journal of Pharmacy and Pharmacology · doi:10.5897/ajpp2014.4145
“Interestingly, evidence (González-Maeso et al., 2008) reported that there was an upregulation of serotonin 5-HT2A receptors and a downregulation of metabotropic glutamate receptors in post-mortem brain from untreated schizophrenic patients, suggesting a pattern that could predispose psychosis.”
BackgroundFuxé, K., & Borroto‐Escuela, D. O. (2022) · Springer eBooks · doi:10.1007/978-3-030-71519-9_189-1
Scheefhals, N. (2022) · Utrecht University Repository (Utrecht University) · doi:10.33540/1224
Changes in Targets as an Explanation for Drug Resistance in Epilepsy
Martínez-Aguirre, C., Fonseca‐Barriendos, D., de la Cruz, S. H., Fuentes-Mejía, M., & Rocha, L. L. (2023) · Springer eBooks · doi:10.1007/978-3-031-36526-3_7
Cummings, J. L. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375523.as35
Bespalov, A., Lütjens, R., & Doller, D. (2024) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2024.173908
CNS Biased Agonism and the Promise of Targeting Drugs Beyond Receptors to Cellular Pathways
Melnick, L. M. (2024) · Springer eBooks · doi:10.1007/978-3-031-61992-2_9
Smith, A. D. T., Jsramillo, N. B., & Cuartas, D. M. B. (2025) · Medical & Clinical Case Reports Journal · doi:10.51219/mccrj/andres-david-turizo-smith/233
A Regional Dopamine-Serotonin Control Model of Conscious StatePreprint
Sousa, D. (2025) · arXiv (Cornell University) · doi:10.48550/arxiv.2507.02614
Assays to read GPCR modulation and signaling
Heilker, R., & Wolff, M. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511760334.013
The functional significance of G protein -coupled receptor dimerization
Whorton, M. R. (2008) · Deep Blue (University of Michigan)
Lane, C. P. (2025) · eScholarship@McGill (McGill) · doi:10.82308/37282
Río-Álamos, C., & Legal, U. A. D. B. D. D. P. I. D. M. (2017) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
Sampedro-Viana, D. (2023) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
Oliveras, I., & Legal, U. A. D. B. D. D. P. I. D. M. (2017) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
Peralta-Vallejo, N. (2024) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
ADGRE2/EMR2 RESEPTÖRÜNÜN HOMO-OLİGOMERİZASYONUNUN BRET VE FRET YÖNTEMLERİ KULLANILARAK BELİRLENMESİ
Öğütcü, D. (2023) · OpenMETU (Middle East Technical University)
Therapeutic effects of mGluR2 modulation with AZD8529 in Parkinson’s disease
Shaqfah, J. (2025) · eScholarship@McGill (McGill) · doi:10.82308/51060
Mojarrad, A., Damirchi, E. S., sheikholeslami, A., Rezaeisharif, A., Abbasi, V., & Homayoon, M. N. (2025) · Research Square · doi:10.21203/rs.3.rs-7948462/v1
Moskaliuk, V., Komleva, P. D., Khotskin, N., Arefieva, A., Shevelev, O., Korablev, A., Serova, I., Battulin, N., Kulikov, A., Naumenko, V., et al. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1730197
Le récepteur orphelin GPR158 : fonction et partenaires protéiques
Hajj, M. (2012) · theses.fr (ABES) · doi:10.70675/e75ab04fzf6ddz4c25zb55dz5eefb493d85c
Metadata
- Authors
- González-Maeso, J., Ang, R. L., Yuen, T., Chan, P., Weisstaub, N. V., López-Giménez, J. F., Zhou, M., Okawa, Y., Callado, L. F., Milligan, G., Gingrich, J. A., Filizola, M., Meana, J. J., & Sealfon, S. C.
- Affiliations
- University of the Basque Country (ES)
- University of Glasgow (GB)
- New York State Psychiatric Institute (US)
- Icahn School of Medicine at Mount Sinai (US)
- Corresponding author
- Sealfon, Stuart C.
- ORCID
- Venue
- Nature
- Published
- 2008-02-24
- Volume
- 452
- Issue
- 7183
- Pages
- 93-97
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC2743172
- OpenAlex
- W2024942419
- Cited by
- 803
- References
- 44
- Citations by year
- 2026: 18 · 2025: 21 · 2024: 23 · 2023: 34 · 2022: 44 · 2021: 38 · 2020: 36 · 2019: 33 · 2018: 45 · 2017: 44 · 2016: 51 · 2015: 37 · 2014: 52 · 2013: 62 · 2012: 71
- FWCI
- 27.83
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- Funders
- National Institute of Mental Health (U01MH083545)
- National Institute on Drug Abuse (T32DA007135, P01DA012923)
- National Institute of General Medical Sciences (T32GM062754)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- 5-HT2A receptor, mGluR2, metabotropic glutamate receptors, receptor complex, schizophrenia, psychosis, hallucinogens, LSD, psilocybin, cortical dysfunction, antipsychotic drug targets, postmortem brain
- MeSH terms
- Animals, Brain, Cell Line, Cells, Cultured, Hallucinogens, Humans, Models, Molecular, Protein Binding, Psychotic Disorders, Schizophrenia, Signal Transduction, Down-Regulation, Up-Regulation, Protein Structure, Tertiary, Receptors, Metabotropic Glutamate, Receptor, Serotonin, 5-HT2A, Multiprotein Complexes, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.